Informacja dotycząca wpływu epidemii wirusa COVID19 na działalność emitenta.
Information on the impact of the COVID19 virus outbreak on the issuer’s activities.
Current report no. 10/2022: Commencement of the procedure for changing the registered office of the company.
Current report no. 9/2022: Submission of the content of the unaudited consolidated annual report for 2021.
Current report no.8/2022: Update of The Information Document.
Current report no.7/2022: Registration of the amendments to the Articles of Association and increase of share capital.
Current report no. 6/2022: Publication of the information document.
Current report no. 5/2022: Notice to shareholders concerning the conduct of the Extraordinary General Meeting convened on 23 May 2022.